AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (11.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Article | Open Access

Identification of key targets and potential mechanisms underlying microglia dysfunction in Alzheimer’s disease based on single-cell transcriptomics and Mendelian randomization

Hai Tang1,2,§Xuemei Liu1,3,§Lingqi Zhou1,§Yue Zhou4( )Lizhi Chen1( )
Department of Science and Education, the Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou 510220, China
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 518107, China
Department of Gynecology, Shunde Hospital of Southern Medical University, Foshan 528300, China
Department of Emergency, TCM-Integrated Hospital of Southern Medical University, Guangzhou 510315, China

§ These authors contributed equally to this work.

Show Author Information

Abstract

Background

The function of key regulatory genes in shaping the immune microenvironment of Alzheimer's disease (AD) remains elusive. Thus, this investigation aimed to detect key targets and potential mechanisms underlying microglia dysfunction in AD based on GWAS and single-cell transcriptomics.

Methods

The present investigation utilized single-cell RNA sequencing (scRNA-seq) with microarray data (GSE243292 and GSE53697) to uncover cellular subtypes and critical regulatory genes linked to AD. Differential gene expression analysis, Mendelian randomization (MR), and immune cell infiltration profiling were performed to identify potential causal genes and their biological pathways. Additionally, miRNA and transcription factor network analyses were conducted to explore gene regulation. Lastly, functional pathway enrichment analysis and correlation studies with AD-related genes were conducted to assess biological significance. This study was conducted without using artificial intelligence (AI) tools in accordance with the TITAN Guidelines 2025.

Results

The findings of scRNA-seq analysis yielded 8 distinct cell subtypes, with microglia being significantly enriched in AD samples. Marker genes of microglia were correlated with pathways like glutamate receptor signaling and actin filament-based processes. Moreover, MR analysis identified EPB41L2, INPP5D, and ZFHX3 as key genes influencing AD risk, which were significantly associated with immune cells like T and B cells. Meanwhile, functional pathway analysis revealed enrichment in the NF-kappa B, TNF signaling, and PI3K-Akt pathways. Finally, miRNA and transcription factor analyses uncovered shared regulatory mechanisms, while correlations with genes such as PSEN1 and NPC1 validated their association with the pathogenesis of AD.

Conclusion

This investigation offers a new understanding of the immune landscape of AD by identifying key genetic regulators and their associated immune pathways.

Electronic Supplementary Material

Download File(s)
AgingRes-2025-0040_ESM.pdf (544.8 KB)

References

【1】
【1】
 
 
Aging Research
Article number: 9340079

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Tang H, Liu X, Zhou L, et al. Identification of key targets and potential mechanisms underlying microglia dysfunction in Alzheimer’s disease based on single-cell transcriptomics and Mendelian randomization. Aging Research, 2026, 4(1): 9340079. https://doi.org/10.26599/AGR.2026.9340079

7

Views

0

Downloads

0

Crossref

Received: 10 December 2025
Revised: 16 April 2026
Accepted: 13 June 2026
Published: 03 August 2026
© The Author(s) 2026. Aging Research published by Tsinghua University Press.

The articles published in this open access journal are distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.